Compare RPRX & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RPRX | EXPD |
|---|---|---|
| Founded | 1996 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 16.3B |
| IPO Year | 2020 | N/A |
| Metric | RPRX | EXPD |
|---|---|---|
| Price | $39.70 | $151.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 10 |
| Target Price | $46.00 | ★ $129.22 |
| AVG Volume (30 Days) | ★ 4.3M | 1.5M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | ★ 2.21% | 1.02% |
| EPS Growth | N/A | ★ 20.10 |
| EPS | 1.75 | ★ 6.15 |
| Revenue | $2,349,844,000.00 | ★ $11,167,760,000.00 |
| Revenue This Year | $37.13 | $3.06 |
| Revenue Next Year | $1.48 | N/A |
| P/E Ratio | ★ $22.68 | $24.64 |
| Revenue Growth | 3.70 | ★ 12.54 |
| 52 Week Low | $24.05 | $100.47 |
| 52 Week High | $41.24 | $151.67 |
| Indicator | RPRX | EXPD |
|---|---|---|
| Relative Strength Index (RSI) | 57.50 | 75.95 |
| Support Level | $39.24 | $144.93 |
| Resistance Level | $40.50 | $147.87 |
| Average True Range (ATR) | 0.91 | 2.89 |
| MACD | -0.08 | 0.18 |
| Stochastic Oscillator | 76.02 | 98.14 |
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 35% of consolidated gross revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.